Multi-Stability and Multi-Instability Phenomena in a Mathematical Model of Tumor-Immune-Virus Interactions
- 8 April 2011
- journal article
- Published by Springer Nature in Bulletin of Mathematical Biology
- Vol. 73 (12) , 2932-2961
Abstract
Recent advances in virology, gene therapy, and molecular and cell biology have provided insight into the mechanisms through which viruses can boost the anti-tumor immune response, or can infect and directly kill tumor cells. A recent experimental report (Bridle et al. in Molec. Ther. 18(8):1430–1439, 2010) showed that a sequential treatment approach that involves two viruses that carry the same tumor antigen leads to an improved anti-tumor response compared to the effect of each virus alone. In this article, we derive a mathematical model to investigate the anti-tumor effect of two viruses, and their interactions with the immune cells. We discuss the conditions necessary for permanent tumor elimination and, in this context, we stress the importance of investigating the long-term effect of non-linear interactions. In particular, we discuss multi-stability and multi-instability, two complex phenomena that can cause abrupt transitions between different states in biological and physical systems. In the context of cancer immunotherapies, the transitions between a tumor-free and a tumor-present state have so far been associated with the multi-stability phenomenon. Here, we show that multi-instability can also cause the system to switch from one state to the other. In addition, we show that the multi-stability is driven by the immune response, while the multi-instability is driven by the presence of the virus.Keywords
This publication has 60 references indexed in Scilit:
- Potentiating Cancer Immunotherapy Using an Oncolytic VirusMolecular Therapy, 2010
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumorsProceedings of the National Academy of Sciences, 2010
- Persistence of Transgene Expression Influences CD8+T-Cell Expansion and Maintenance following Immunization with Recombinant AdenovirusJournal of Virology, 2009
- Vesicular Stomatitis Virus as a Novel Cancer Vaccine Vector to Prime Antitumor Immunity Amenable to Rapid Boosting With AdenovirusMolecular Therapy, 2009
- Dynamics of multiple myeloma tumor therapy with a recombinant measles virusCancer Gene Therapy, 2009
- Towards Predictive Computational Models of Oncolytic Virus Therapy: Basis for Experimental Validation and Model SelectionPLOS ONE, 2009
- Attenuation of Recombinant Vesicular Stomatitis Virus-Human Immunodeficiency Virus Type 1 Vaccine Vectors by Gene Translocations and G Gene Truncation Reduces Neurovirulence and Enhances Immunogenicity in MiceJournal of Virology, 2008
- Persistent Antigen Presentation after Acute Vesicular Stomatitis Virus InfectionJournal of Virology, 2007
- From Disorder to Order in Marching LocustsScience, 2006
- Lineage relationship and protective immunity of memory CD8 T cell subsetsNature Immunology, 2003